Related by context. All words. (Click for frequent words.) 69 pharmacological chaperone 63 Plicera 62 JAK inhibitors 62 docetaxel Taxotere R 62 therapeutic monoclonal antibodies 62 novel therapeutic antibodies 61 Ceflatonin R 61 novel peptide 61 novel antibody therapeutics 61 TLR9 agonists 61 entinostat 61 adenosine A2A 60 antisense inhibitors 60 HuLuc# 60 thiazolides 60 JAK inhibitor 60 ENMD # 60 Ostarine ™ 60 engineered RAP peptides 60 Aviptadil 60 anticoagulant reversing agent 60 MEK inhibitor 60 HCV protease inhibitor 60 HQK 60 histone deacetylase inhibitor 60 THR beta agonist 60 kidney urologic 60 adrenergic regulation 60 targeted radiotherapeutic 59 novel peptides 59 YONDELIS 59 oral prodrug 59 BCR ABL inhibitors 59 PKC# 59 L BLP# 59 epothilones 59 FOLOTYN ® 59 selective androgen receptor modulators 59 ALN PCS 59 HGS ETR1 mapatumumab 59 peptibody 59 trastuzumab Herceptin R 59 tiapamil 59 CCR9 antagonist 59 therapeutic monoclonal antibody 59 IMiDs 59 proprietary PEGylation 59 ALN TTR 59 Ceflatonin 59 Smac mimetics 59 small molecule defensin 59 humanized anti 59 Selective Electrochemical Tumor Ablation 59 candidate custirsen 59 commercialize SGN 58 small molecule modulators 58 CD# CEA 58 oral Janus kinase 58 CEQ# 58 TACI Ig 58 PI3K/Akt pathway inhibitor 58 castrate resistant prostate cancer 58 Oracea TM 58 Vaccinex 58 myeloproliferative disorders 58 ZFP Therapeutics 58 ImmunoGen TAP technology 58 infectious diseases autoimmune 58 stable nucleic acid 58 telomerase therapeutic 58 Campath ® 58 ATL# [001] 58 Miraxion Amarin lead 58 targeting PCSK9 58 Insegia 58 immatics 58 Reports Preclinical Data 58 anticancer compounds 58 IMiDs R 58 FoldRx Pharmaceuticals Inc. 58 commercialize becocalcidiol patented 58 novel antiviral therapeutics 58 Sphingomab TM 58 Xcytrin R 58 KNS # 58 CYT# potent vascular disrupting 58 AKT inhibitor 58 MAbs targeting 58 NovaBay Aganocide compounds 58 personalized cellular immunotherapy 58 Aurora kinase inhibitor 58 Locked Nucleic Acid LNA 58 injectable collagenase 58 Aurora kinase 57 isoform selective 57 MERREM 57 Homspera TM 57 gefitinib Iressa 57 targeting CD# 57 Combivir Kivexa 57 Modrenal R 57 polymerase inhibitors 57 SARMs 57 Fc fusion protein 57 candidates Azedra TM 57 Stapled Peptide 57 virus HCV protease inhibitor 57 orally bioavailable 57 ViaCyte 57 multi kinase inhibitor 57 Telik logo TELINTRA 57 ADI PEG 57 BHT DNA 57 PRT# 57 preclinically 57 delay bone metastases 57 Homspera ® 57 XL# anticancer compounds 57 Fx #A 57 Personalized Immunotherapy 57 exon skipping 57 HCV polymerase 57 preclinical compounds 57 SAR# [002] 57 monoclonal antibody therapeutics 57 SinuNase ™ 57 ALN TTR# 57 Romidepsin 57 oncolytic virus therapies 57 histone methyltransferases HMTs 57 AAG geldanamycin analog 57 histone deacetylase HDAC inhibitor 57 RNAi therapeutic targeting 57 rxRNA 57 intranasal formulation 57 ASG 5ME 57 Dacetuzumab 57 dimebon latrepirdine 57 oral ghrelin agonist 57 docetaxel Taxotere ® 57 Selzentry Celsentri 57 Initiates Enrollment 57 ArQule Kinase Inhibitor Platform 57 MTP inhibitor 57 Omacetaxine 57 HepeX B TM 57 novel immunomodulatory 57 enzastaurin 57 DPX Survivac 57 P#X# antagonist 57 Adnectin 57 TTR amyloidosis 57 optimal dosing regimens 57 evaluating picoplatin 57 Dacogen injection 57 HuMax TAC 57 PSMA ADC 57 nicotinic alpha 7 57 Receptos 57 Li Fraumeni Syndrome 56 YONDELIS R 56 Azedra 56 ALN HTT 56 TRACON Pharmaceuticals 56 Panzem 56 Davanat 56 systemically administered 56 Archexin 56 myelofibrosis polycythemia vera 56 Avila Therapeutics 56 commercialize OncoGenex lead 56 MEK inhibitors 56 Guanilib 56 ADVEXIN p# therapy 56 Friedreich Ataxia FRDA 56 R sorafenib tablets 56 acadesine 56 ZEVALIN ® 56 aerosolized AAT 56 Lumacan 56 velafermin belinostat 56 PNT# 56 IAP inhibitors 56 liposomal formulation 56 deforolimus 56 HGS# 56 vaccines oncolytic virus 56 IMA# 56 Avian Transgenic Technology 56 delivered RNAi therapeutic 56 HCV protease 56 ASONEP 56 Elotuzumab 56 molecular chaperone regulation 56 MKC# MKC# PP 56 Bioral Amphotericin B 56 Evoltra ® 56 oncolytic viruses 56 anticancer therapeutics 56 Panzem R 56 targeted anticancer biopharmaceuticals 56 peptidic compound 56 immunotherapeutic approaches 56 cMET 56 CytoFab 56 PDE4 inhibitor 56 investigational therapies 56 next generation URAT1 56 investigational humanized monoclonal antibody 56 biologic therapeutics 56 Hematide ™ 56 Initiates Phase II 56 Aganocide ® 56 antisense drugs 56 commercialize XP# 56 JOULFERON 56 memantine HCl 56 oral Azacitidine 56 AMPK activators 56 Symadex 56 Zalypsis 56 theranostic 56 KuDOS 56 PDE# inhibitors 56 HSP# inhibitor 56 vinca alkaloid 56 Presents Preclinical Data 56 TRAIL receptor antibodies 56 antiangiogenesis therapies 56 Genasense evaluating 56 kinase inhibitor 56 Fleximer 56 ABL inhibitor 56 HIV RDEA# 56 Prodarsan ® 56 Onalta TM 56 transthyretin TTR mediated amyloidosis 56 LymphoStat B TM 56 psoriasis rheumatoid arthritis 56 Pancreate 56 Viprovex TM 56 commercialize deforolimus 56 multicenter Phase II 56 novel anti infective 56 mertansine 56 novel RNAi therapeutics 56 midstage clinical 56 IMiDs ® compound 56 Sangamo ZFP technology 56 pan histone deacetylase 56 otelixizumab 56 PNP inhibitor 56 compound ITMN 56 engineered proteases 56 erlotinib Tarceva ® 56 pralatrexate injection folate analogue 56 Duchenne muscular dystrophy DMD 56 anti CD3 monoclonal 55 mda 7 55 developing Zerenex TM 55 candidate deforolimus 55 Pervasis 55 acetonide FA 55 leading oral taxane 55 Initiates Clinical Trial 55 Vitamin D analogue 55 molecular biomarkers 55 INSPIRE Trial Phase III 55 small molecule agonists 55 Curaxin 55 Quark Biotech Inc. 55 romazarit 55 Amigal TM 55 PD LID 55 Crofelemer budesonide foam 55 PEGylated Fab fragment 55 cardio renal 55 gastro intestinal inflammation 55 Chrysalin 55 NS5b 55 OncoVEX 55 GW# [003] 55 Factor VIIa 55 selective kinase inhibitor 55 hypoxia selective 55 DiLA2 55 molecular imaging radiopharmaceuticals 55 CD4 monoclonal antibody 55 Traficet EN 55 JAK1 55 non nucleoside inhibitor 55 PXD# 55 recombinant subunit vaccine 55 cancer immunotherapies 55 Prodarsan R 55 reverse vaccinology 55 platform HDL Mimetic 55 osteolytic bone disease 55 dermatology therapies 55 teplizumab 55 pan HDAC inhibitor 55 neuronal nicotinic receptors NNRs 55 immunologic diseases 55 modified glutathione analog 55 Ceflatonin ® 55 metaglidasen 55 RNA antagonists 55 targeted immunotherapies 55 histone deacetylase HDAC 55 reslizumab 55 novel immunotherapies 55 Rigel R# 55 TRO# 55 miRNA therapeutics 55 XL# XL# XL# 55 hematologic disorders 55 Pentad TM 55 hypoxia activated prodrug 55 Hsp# inhibition 55 HSP# inhibitors 55 lead molecular radiotherapeutic 55 defensin mimetic antibiotic 55 telomerase inhibitor drug 55 ATL# [002] 55 intravesical infusion therapy 55 AtuPLEX 55 LEVADEX ™ 55 LY# [003] 55 Aganocide 55 tranilast 55 Fleximer R 55 Onalta 55 ELND-#/AZD-# 55 HuMax EGFr 55 Sapacitabine 55 Veronate R 55 vapreotide acetate 55 3 kinase PI3K 55 skeletal muscle weakness 55 Tarmogen 55 antisense drug 55 Nanobody 55 Viprovex R 55 NNR Therapeutics 55 Silodosin 55 antisense therapeutics 55 investigational compounds 55 liver cancers hypercholesterolemia 55 Solazed TM 55 urocortin 2 55 receptor inhibiting monoclonal 55 orally administered inhibitor 55 refractory chronic lymphocytic 55 predictive biomarkers 55 clinically validated targets 55 IMiDs ® 55 XL# XL# 55 developing TB4 55 BENLYSTA ® 55 VitiGam 55 GED aPC 55 enhance ApoA 55 siRNA therapeutics 55 volociximab 55 Novosom 55 alvespimycin 55 Curaxin CBLC# 55 refractory gout 55 sapacitabine CYC# 55 sodium thiosulfate STS 55 BXT # 55 Regado Biosciences 55 gamma secretase inhibitor 55 GI motility disorders 55 radezolid 55 Pharma Merck Serono 55 regorafenib 55 4SC AG ISIN DE# 55 ALN VSP 55 IAP inhibitor 55 omacetaxine 55 transthyretin mediated amyloidosis ATTR 55 PEG SN# 55 Angiocept 55 Arno Therapeutics 55 skeletal muscle contractility 55 catalytic antioxidant compounds 55 trastuzumab DM1 T DM1 55 IMPACS R 55 elotuzumab 55 cetuximab Erbitux R 55 beta 1a 55 agonistic human 55 Iluvien ® 54 oncology therapeutics 54 GATTEX ® 54 Survivin antagonist 54 selective angiogenic kinase inhibitor 54 receptor tyrosine kinase inhibitor 54 biochemical profiling 54 orally administered synthetic retinoid 54 novel orally administered 54 Epothilones 54 Provectus Pharmaceuticals specializes 54 Squalamine 54 huC# DM4 54 Sudhir Agrawal D.Phil 54 Surfaxin LS 54 antibacterial therapeutics 54 immuno inflammatory diseases 54 pafuramidine maleate 54 siRNA therapeutic 54 MCSP respectively 54 PluriCells TM 54 protein kinase inhibitors 54 HCV protease inhibitors 54 E2F Decoy 54 R MSCRAMM 54 Adenosine Therapeutics 54 markets COLAZAL 54 Nanobody R 54 BCR ABL inhibitor 54 fusion enhancers 54 MSCRAMM ® 54 DOS# 54 PHX# 54 investigational monoclonal antibody 54 AEG# 54 small molecule inhibitors 54 RECOTHROM ® 54 HCV NS5B polymerase 54 Kosan epothilone program 54 manufactures minimally invasive 54 Anticalins R 54 oral Hsp# inhibitor 54 commercialize microRNA 54 AN# novel 54 DURECT proprietary 54 identify protein biomarkers 54 biodefense pathogens 54 dihydrochloride Tablets 54 MAGE A3 ASCI 54 Alligator Bioscience AB 54 cathepsin K inhibitor 54 HepeX B 54 RH1 54 LymphoStat B belimumab 54 purinergic receptors P#X# 54 delivers fluocinolone acetonide FA 54 favorable pharmacokinetic profile 54 product platforms AZX# 54 adecatumumab MT# 54 Kosan dependence 54 Locked Nucleic Acid 54 investigational HCV polymerase 54 FoldRx 54 RTP #i 54 NTDDS 54 vemurafenib 54 topical anti infective 54 tubulin inhibitor 54 Triolex 54 Vitaxin 54 immunological diseases 54 Enhanze TM Technology 54 LHRH antagonist 54 Wellstat 54 StemEx R 54 candidate epratuzumab 54 lesinurad 54 Syntonix 54 Presents Preclinical 54 toenail onychomycosis 54 Troxatyl 54 Annamycin 54 ALV# 54 Aurexis 54 BioNumerik 54 hyaluronidase enzyme 54 nalbuphine ER 54 neuropathic pain metabolic diseases 54 Naglazyme R 54 cyclophilin inhibitors 54 Bicifadine 54 essential thrombocythemia ET 54 lead Aganocide compound 54 anticancer compound 54 commercialize pimavanserin 54 oral dihydropyrimidine dehydrogenase DPD 54 Zenvia ™ 54 selective inhibition 54 Nasdaq LXRX biopharmaceutical 54 ZFNs clinical trials 54 DepoBupivacaine TM 54 pentadentate logo R 54 topically applied SEPA 54 lipid nanoparticle 54 CR# vcMMAE 54 neuronal nicotinic receptor NNR 54 LUCASSIN 54 Tarvacin TM 54 TM Aganocide 54 biomarker assays 54 Ibis T# TM 54 MEK inhibitor RDEA# 54 CCR5 mAb 54 antibody therapies 54 oral JAK#/JAK# inhibitor 54 validating biomarkers 54 LentiVector technology 54 hormone LHRH antagonist 54 lorvotuzumab mertansine 54 Tß4 54 vitreoretinal disorders 54 Protein Kinase C 54 sirtuin therapeutics 54 forodesine 54 Spiegelmers R 54 potently inhibit 54 Pagoclone 54 Inc. Nasdaq ALNY 54 poly ADP ribose polymerase 54 PDX pralatrexate 54 Scancell 54 Alocrest 54 Pruvel ™ 54 OMP #R# 54 Poly ICLC 54 Phase IIb clinical trials 54 Vegenics 54 SPL# Gel vaginal microbicide 54 Helsinn Healthcare 54 Lixivaptan 54 systemic RNA interference 54 RNAi therapeutic 54 M2 subunit 54 ddRNAi 54 EC Cysteamine 54 lipid particles SNALP 54 bevacizumab Avastin R 54 Levulan ® PDT 54 pharmacogenetic test 54 CCX# 53 Albugon 53 Exherin TM 53 topical dermatological products 53 sulfonylhydrazine class 53 Delta opioid receptor 53 fatty acid amide hydrolase 53 relapsed leukemia 53 Actilon 53 Androxal TM 53 anticancer therapies 53 Apexigen 53 markets Testim ® 53 Lenocta 53 Cancidas 53 humanized monoclonal antibody 53 TRANSDUR ® 53 R#/MEM # 53 derivatives Radilex TM 53 CYT# novel 53 Aflibercept 53 HGS ETR1 53 neovascular diseases 53 ETBs 53 Initiates Clinical 53 Revimmune TM 53 MDRNA proprietary 53 synthetic retinoid 53 investigational pan BCR 53 IMiD 53 IL# PE#QQR 53 MyVax R 53 candidate REP# 53 diabetes irritable bowel 53 Nasdaq IDIX biopharmaceutical 53 NASDAQ PHRM 53 Soliris eculizumab 53 hyperphosphorylation 53 radiotherapeutic 53 drug conjugate 53 OTCBB PYTO 53 MKC# MT 53 nitric oxide donating 53 Trofex 53 HCV nucleotide polymerase inhibitor 53 commercialize apixaban 53 HDL Mimetic Peptide 53 drug ISA# 53 Epiphany Biosciences 53 GVAX ® 53 bendamustine HCl 53 Nasdaq IMGN biotechnology 53 mitogen activated ERK kinase 53 acyclovir Lauriad R 53 ThermoDox ® clinical 53 oral proteasome inhibitor 53 methylnaltrexone 53 Pimavanserin 53 Antibody Drug Conjugate 53 Mersana Therapeutics 53 ACTCellerate 53 Merck OSI Pharmaceuticals 53 ospemifene 53 compound INCB# 53 Completes Patient Enrollment 53 R vancomycin hydrochloride 53 anionic backbone 53 gastrin analogue TT 53 Vectibix panitumumab 53 Aeolus Pharmaceuticals Announces 53 thetreatment 53 HCV NS3 protease 53 symbol AVXL 53 Cethrin R 53 Tezampanel 53 TRIOLEX HE# APOPTONE HE# 53 HGS ETR2 53 PD2i CA Cardiac Analyzer 53 Triapine 53 evaluating satraplatin 53 TYZEKA 53 Excaliard 53 RNA antagonist 53 Tumour Vascular Disrupting Agent 53 RGB # 53 small molecule activators 53 Civacir 53 cosmetic cosmeceutical products 53 Erbitux cetuximab 53 MT#/MEDI-# 53 Etubics 53 neuro inflammatory 53 TRIOLEX 53 EnVivo Pharmaceuticals 53 Xanthus Pharmaceuticals Inc. 53 Cethrin 53 theranostics 53 Nasdaq IDRA 53 GSK# [002] 53 immune modulation 53 Archemix Corp. 53 delta opioid receptor 53 antisense oligonucleotides 53 DNA methyltransferase inhibitors 53 Inc. OTCBB IRBS 53 CD# expressing 53 mitiglinide 53 JAK2 Inhibitor 53 HCD# [002] 53 Budesonide foam crofelemer 53 Panzem NCD 53 lexidronam injection 53 Hedgehog pathway 53 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 53 Oral NKTR 53 PrevOnco ™ 53 Pervasis Therapeutics Inc. 53 prokinetic agent 53 Nexavar tablets 53 anti infective treatments 53 Chimigen TM 53 epothilone 53 oral nucleoside analogue 53 Allovectin 7 R 53 PLX MS 53 compound PMX # 53 proprietary biomaterials 53 humanized antibodies 53 EHT AGN 53 Cx# [002] 53 Neurimmune 53 JAK2 inhibitor 53 Bezielle 53 Wnt signaling pathway 53 tkRNAi 53 Inc. Nasdaq IMGN 53 AKIP TM 53 G Protein Coupled 53 lintuzumab SGN 53 vaccine GRNVAC1 53 GLYX 53 Injury ALI 53 protein therapeutics 53 protein misfolding diseases 53 alpha folate receptor 53 Sym# 53 highly selective adenosine 53 RhuDex ® 53 epigenetic enzymes 53 monoclonal antibody 53 commercialize Aganocides 53 monoclonal antibody therapies 53 transthyretin TTR 53 Alzhemed TM 53 small molecule 53 PsychoGenics 53 KL4 surfactant 53 beta secretase inhibitors 53 OGeS 53 drugable targets 53 hypervascular tumors 53 inflammatory autoimmune diseases 53 NASDAQ ABII 53 oncolytic 53 Georges Gemayel 53 renin inhibition promising 52 Quinamed R 52 humanised antibody 52 NGX# 52 rheumatoid arthritis psoriasis Crohn 52 OMAPRO ™ 52 cell lymphoma CTCL 52 Nanobody ® 52 Luveris R Ovidrel R 52 generation radiolabeled antibody 52 antibody MAb 52 ketolide antibiotic 52 ZFP TF 52 skeletal sarcomere activators 52 sells Osteocel R 52 synthetic cannabinoid compounds 52 oral picoplatin 52 RNA therapeutics 52 Protexia R 52 Tesetaxel 52 Metallophile ™ Technology 52 LNP formulations 52 SNALP technology 52 Phase 1b trial 52 FOLFOX6 chemotherapy regimen 52 GGF2 52 PROfusion 52 NexGenix 52 GLPG# 52 Celator 52 Fabry Disease 52 acne impetigo 52 anti amnesic 52 INCB# [001] 52 Microplasmin 52 Inc. www.micromet inc.com 52 TBC# 52 siRNA compounds 52 FOLFOX chemotherapy 52 ELADUR ™ 52 TLR8 52 Receptors GPCRs 52 accumulate preferentially 52 KineMed 52 belinostat 52 fibrotic disease 52 CCR1 52 Phase Ib study 52 please visit http:/www.sunesis.com 52 polyneuropathy HIV DSP 52 molecular imaging radiopharmaceutical 52 oral dual endothelin 52 faropenem 52 rheumatoid arthritis multiple sclerosis 52 Familial Adenomatous Polyposis FAP 52 Exherin 52 carbohydrate polymers 52 phase IIb clinical 52 CoFactor 52 biologic therapies 52 SIRT1 activators 52 pharmacogenomic tests 52 vascular disrupting agent 52 Acute Radiation Syndrome ARS 52 pharmacogenomic translational research 52 rheumatoid arthritis psoriasis 52 investigational hepatitis C 52 VEGFR2 inhibitor 52 therapeutic peptide 52 OTC BB PVCT 52 Nasdaq HALO biopharmaceutical 52 Oasmia 52 interferon gamma 1b 52 humanized monoclonal antibodies 52 coronary stent merged 52 www.ucb group.com 52 superior bioprocessing 52 Azedra TM 52 Kinase Inhibitor 52 doxorubicin Transdrug R 52 Cannabinor 52 molecular therapeutics immunotherapies 52 pexiganan 52 anti botulism antibody 52 mitotic kinesins 52 SIX RO ROG 52 plasma kallikrein inhibitor 52 DsiRNA 52 ALN HPN 52 orally inhaled migraine 52 Fibrocell Science 52 dasatinib Sprycel ® 52 virus AAV 52 ZFP Therapeutic 52 secretory phospholipase A2 sPLA2 52 polysaccharide polymer 52 mGluR5 negative 52 telaprevir VX 52 NU# direct 52 APOPTONE 52 investigational oral hepatitis C 52 Fibroblast Growth Factor Receptor 52 AKIP ™ 52 developing Zerenex ferric 52 pDNA vaccine 52 phase IIa clinical 52 NNRs 52 target Galectin receptors 52 polymerase inhibitor 52 ErbB3 HER3 52 imatinib Gleevec ® 52 MT# MEDI 52 Piramed 52 Debio 52 MPS VI 52 biosurgical 52 Epeius Biotechnologies Corporation 52 Zemiva TM 52 metastatic neuroendocrine tumors 52 Virulizin 52 PORxin TM 52 histone deacetylase 52 NYSE Amex PBTH 52 Salmonella vector 52 A3 adenosine receptor 52 pain palliation 52 Cutanea 52 TLR7 agonist 52 myeloproliferative neoplasms MPNs 52 Curaxins 52 developing adecatumumab 52 KSP inhibitor 52 terlipressin 52 mGluR4 PAM 52 coagulation disorders 52 MP4 molecule 52 CRLX# 52 epilepsy Parkinson disease 52 infectious diseases autoimmune diseases 52 Syndrome LEMS 52 orthobiologic 52 Nasdaq XTLB 52 Revimmune 52 Astellas Deutschland GmbH 52 Retacrit 52 Nexavar sorafenib 52 deCODE chemistry 52 Cinquil 52 topical gel formulation 52 Calistoga Pharmaceuticals 52 HuMax CD4 52 candidate CRLX# 52 antibody fragment therapeutics 52 Pruvel TM 52 IMC #F# 52 fosbretabulin 52 RNAi Therapeutic 52 Merrimack Pharmaceuticals 52 Cellzome 52 anticancer agents 52 Zybrestat 52 Genasense ® oblimersen 52 ALN RSV program 52 CRMD# 52 apoptosis proteins 52 c Raf kinase 52 ZBx 52 KL4 Surfactant 52 OMNARIS HFA 52 neuroprotective properties 52 Enkephalin 52 ATRA IV 52 NuMimetic TM 52 LNPs 52 ELACYT 52 seliciclib CYC# 52 Phase Ib II 52 Kleanthis G. Xanthopoulos Ph.D. 52 Solazed ™ 52 HCV antiviral 52 p# inhibitor 52 selective kinase inhibitors 52 Erimos 52 Acute Myeloid Leukemia AML 52 ALTROPANE R 52 Inc. Nasdaq INFI 52 SAR# [004] 52 immunotherapeutics 51 OTCBB HXBM developer 51 TNFerade ™ 51 BiTE antibody 51 Raf kinase inhibitor 51 Phase Ib clinical 51 Therapeutic Competitors Companies 51 TELINTRA 51 RenaZorb TM 51 Hsp# Inhibitor 51 Ltd. OTCBB IMUC 51 Nasdaq RXII 51 AvalonRx ® 51 Inc. AMEX YMI 51 AVN# [001] 51 peripherally acting 51 Inc. NASDAQ TRGT 51 DepoVax ™ 51 apricitabine ATC 51 Aplidin R 51 Begins Dosing 51 cutaneous T 51 AB OMXS BINV 51 NASDAQ SNTA biopharmaceutical 51 metastatic castration resistant 51 ongoing Phase IIIb 51 Alvine Pharmaceuticals 51 By JAMAAL ABDUL 51 evaluating tivozanib 51 Affibody 51 Ore Pharmaceuticals 51 liposomal delivery 51 Nasdaq IDIX 51 orally administered pharmacological chaperones 51 nucleoside tide 51 pharmacokinetic PK study 51 antiviral compounds 51 Genaera Corporation 51 ocular formulation 51 SNT MC# 51 RONDEL ™ 51 Pyridorin 51 oncology indications 51 Spiegelmers ® 51 NEUGENE R 51 PCK# 51 MyVax ® 51 RNAi therapeutic platform 51 inflammatory autoimmune 51 Loramyc R 51 Nasdaq CYTR biopharmaceutical 51 gastrointestinal disorders ATI 51 VisEn Medical 51 constipation OIC 51 Announces Poster Presentations 51 Rhucin ® recombinant 51 StromaCel Inc. 51 TKM Ebola 51 FGFR 51 Nuron Biotech 51 ARRY # 51 axitinib 51 AAV vector 51 ularitide 51 selectin antagonist 51 ProLindac TM 51 commercialize microRNA therapeutics 51 Pancreas Cancer Vaccine 51 InterfeRx 51 including eniluracil ADH 51 mitoxantrone concentrate 51 triciribine phosphate monohydrate 51 Drew Fromkin President 51 nilotinib Tasigna ® 51 commercializing aptamer therapeutics 51 VISICOL R 51 active AKT inhibitor 51 peptide peptide mimetic 51 Lisofylline LSF 51 proliferative diseases 51 Abbokinase 51 JAK2 kinase 51 Myrexis Inc. 51 Posiphen 51 inhibit KSP 51 leukotriene pathway 51 CAMBRIDGE Mass. Alnylam Pharmaceuticals 51 TKB# 51 protein tyrosine phosphatase 1B 51 include Altastaph TM 51 Pharmos proprietary 51 PrevOnco 51 non nucleoside HCV 51 clofarabine 51 IMPDH inhibitor 51 siRNA delivery 51 Multiferon 51 please visit www.metabolon.com 51 non alcoholic steatohepatitis 51 activate SIRT1 51 OHR/AVR# 51 PEGPH# 51 Nabi HB Intravenous 51 Unit Dose Budesonide 51 GLASSIA